Concepedia

S. Giessinger

SG

3

Publications

283

Citations

3

H-Index

2007

Active since

Affiliations

Houston Methodist(Current)

S. Giessinger is an author at Houston Methodist specializing in molecular oncology, cancer therapeutics, and oncology.

Top concepts

Publications per year

2007–2009

3

Publications

3

A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer

Robert J. Amato, J. Jac, S. Giessinger et al. · Cancer · 2009 · 202 citations · Full text

A phase II trial of RAD001 in patients (Pts) with metastatic renal cell carcinoma (MRCC)

J. Jac, S. Giessinger, Muhammad Khan et al. · Journal of Clinical Oncology · 2007 · 54 citations

, , +16

A phase II study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic renal cell carcinoma which has progressed on tyrosine kinase inhibition therapy

J. Jac, R. J. Amato, S. Giessinger et al. · Journal of Clinical Oncology · 2008 · 27 citations

, , +12

Rows per page

1–3 of 3